Bio-Rad Laboratories Inc
(NYSE:BIO)
$
282.85
-9.65 (-3.3%)
Market Cap: 7.59 Bil
Enterprise Value: 7.40 Bil
PE Ratio: 46.60
PB Ratio: 1.11
GF Score: 72/100 Bio Rad Laboratories Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 19, 2026 / 12:30PM GMT
Release Date Price:
$281.05
(-0.27%)
Dan Leonard
RBC Capital Markets - Analyst
I'm Dan Leonard, the life science tools and diagnostics analyst at RBC. And we're thrilled to have with us from Bio-Rad, Roop Lakkaraju, CFO; and Ruben Argueta from Investor Relations. Thank you both for joining.
Roop Lakkaraju
Bio Rad Laboratories Inc - Chief Financial Officer, Executive Vice President
Thanks for having us, Dan. Appreciate it.
Questions & Answers
Dan Leonard
RBC Capital Markets - Analyst
So we've got some ground to cover in only 25 minutes to do it, I thought, Roop, to set the table, if you could just reflect back on your recently reported quarter, what worked, what were the challenges?
Roop Lakkaraju
Bio Rad Laboratories Inc - Chief Financial Officer, Executive Vice President
Yes. We reported first quarter results at the end of April. Obviously, it's a dynamic environment and markets continue to evolve. I think for us, maybe I'll highlight a few different things. Number one, when I look at where
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot